Teaching adolescents about the dangers of e-cigarettes
Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit
This study is all about helping middle and high school students learn the truth about e-cigarettes and make healthier choices through a fun program called 'Be Vape-Free,' which includes five sessions filled with important discussions about the risks of nicotine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10923920 on NIH RePORTER |
What this research studies
This research focuses on educating middle and high school students about the risks associated with e-cigarette use through a curriculum called 'Be Vape-Free.' The program consists of five sessions designed to correct misconceptions about e-cigarettes and promote healthier choices. By utilizing a community-based participatory approach, the curriculum aims to engage students and educators in meaningful discussions about nicotine addiction and its health impacts. The program is part of a larger Tobacco Prevention Toolkit that has been widely used in schools across the United States.
Who could benefit from this research
Good fit: Ideal candidates for this research are middle and high school students aged 12-18 who are exposed to e-cigarette marketing and may have misconceptions about their safety.
Not a fit: Patients who are not in the adolescent age group or who do not attend schools participating in the program may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce e-cigarette use among adolescents, leading to improved health outcomes.
How similar studies have performed: Previous research has shown that school-based tobacco prevention programs can be effective, but this specific approach to e-cigarette education is relatively novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Halpern-Felsher, Bonnie L — Stanford University
- Study coordinator: Halpern-Felsher, Bonnie L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.